Xiaoshen Zhang

801 total citations
36 papers, 585 citations indexed

About

Xiaoshen Zhang is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiaoshen Zhang has authored 36 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Xiaoshen Zhang's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (5 papers) and MicroRNA in disease regulation (4 papers). Xiaoshen Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (5 papers) and MicroRNA in disease regulation (4 papers). Xiaoshen Zhang collaborates with scholars based in China, United States and Poland. Xiaoshen Zhang's co-authors include Sha Zhao, Yayi He, Keyi Jia, Lingxiao Pan, Wei Tang, Juan Deng, Lun Chen, Wenbo Zheng, Jin Gao and Caicun Zhou and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaoshen Zhang

31 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoshen Zhang China 14 249 247 163 133 83 36 585
Lucas Fass United States 3 208 0.8× 126 0.5× 95 0.6× 100 0.8× 55 0.7× 9 446
Fuchun Guo China 16 400 1.6× 269 1.1× 181 1.1× 156 1.2× 118 1.4× 28 706
Minhong Tang Ireland 9 339 1.4× 256 1.0× 74 0.5× 84 0.6× 58 0.7× 14 563
Xiaoyi Zhang China 12 161 0.6× 230 0.9× 90 0.6× 125 0.9× 66 0.8× 38 487
Bingchen Han United States 12 434 1.7× 342 1.4× 180 1.1× 49 0.4× 82 1.0× 16 767
Santanu Maji United States 11 297 1.2× 165 0.7× 101 0.6× 86 0.6× 43 0.5× 19 492
Sahar Safaei Iran 15 349 1.4× 287 1.2× 185 1.1× 186 1.4× 103 1.2× 31 722
Rongkai Xie China 11 280 1.1× 245 1.0× 171 1.0× 105 0.8× 62 0.7× 23 540
Zike Yang China 6 219 0.9× 130 0.5× 114 0.7× 89 0.7× 46 0.6× 12 419

Countries citing papers authored by Xiaoshen Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaoshen Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoshen Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoshen Zhang more than expected).

Fields of papers citing papers by Xiaoshen Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoshen Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoshen Zhang. The network helps show where Xiaoshen Zhang may publish in the future.

Co-authorship network of co-authors of Xiaoshen Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoshen Zhang. A scholar is included among the top collaborators of Xiaoshen Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoshen Zhang. Xiaoshen Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaoshen, Yaokai Wen, Fengying Wu, et al.. (2025). GSTA1 Conferred Tolerance to Osimertinib and Provided Strategies to Overcome Drug-Tolerant Persister in EGFR-Mutant Lung Adenocarcinoma. Journal of Thoracic Oncology. 21(3). 103494–103494.
2.
3.
Zhang, Y., et al.. (2025). Manganese‐regulated accumulation of carotenoids and abscisic acid in sweet potato through multi‐omics analysis. Journal of the Science of Food and Agriculture. 105(10). 5216–5226. 1 indexed citations
4.
5.
Zhang, Xiaoshen, Yaokai Wen, Fengying Wu, et al.. (2024). RAC1 inhibition ameliorates IBSP-induced bone metastasis in lung adenocarcinoma. Cell Reports. 43(8). 114528–114528. 2 indexed citations
6.
Zhang, Xiaoshen, et al.. (2024). Multi-omics with dynamic network biomarker algorithm prefigures organ-specific metastasis of lung adenocarcinoma. Nature Communications. 15(1). 9855–9855. 7 indexed citations
7.
Zhang, Xiaoshen, Guanghui Gao, Qian Zhang, et al.. (2024). In-depth proteomic analysis identifies key gene signatures predicting therapeutic efficacy of anti-PD-1/PD-L1 monotherapy in non-small cell lung cancer. Translational Lung Cancer Research. 13(1). 34–45. 3 indexed citations
8.
9.
Zhang, Xiaoshen & Lun Chen. (2023). MiR 216b modulates cisplatin resistance and stem cell like features in breast cancer cells by targeting E2F4. Tropical Journal of Pharmaceutical Research. 22(1). 1–7. 1 indexed citations
10.
Song, Xinyu, Anwen Xiong, Fengying Wu, et al.. (2023). Spatial multi-omics revealed the impact of tumor ecosystem heterogeneity on immunotherapy efficacy in patients with advanced non-small cell lung cancer treated with bispecific antibody. Journal for ImmunoTherapy of Cancer. 11(2). e006234–e006234. 40 indexed citations
11.
Pan, Lingxiao, et al.. (2022). Host-guest complexation of cyclophosphamide by carboxylatopillar[6]arene for increasing stability and enhancing its curative effect on breast carcinoma. Bioorganic & Medicinal Chemistry Letters. 78. 129060–129060. 2 indexed citations
12.
Li, Wěi, Hao Wang, Bin Chen, et al.. (2020). Anti PD-1 monoclonal antibody induced autoimmune diabetes mellitus: a case report and brief review. Translational Lung Cancer Research. 9(2). 379–388. 6 indexed citations
13.
He, Yayi, Keyi Jia, Rafał Dziadziuszko, et al.. (2019). Galectin-9 in non-small cell lung cancer. Lung Cancer. 136. 80–85. 36 indexed citations
14.
Tan, Weige, Xinhua Xie, Lun Chen, et al.. (2019). Construction of an immune-related genes nomogram for the preoperative prediction of axillary lymph node metastasis in triple-negative breast cancer. Artificial Cells Nanomedicine and Biotechnology. 48(1). 288–297. 19 indexed citations
15.
Jia, Keyi, Yayi He, Rafał Dziadziuszko, et al.. (2019). T cell immunoglobulin and mucin-domain containing-3 in non-small cell lung cancer. Translational Lung Cancer Research. 8(6). 895–906. 34 indexed citations
16.
Fan, Guoqiang, Limin Wang, Minjie Deng, et al.. (2016). Changes in Transcript Related to Osmosis and Intracellular Ion Homeostasis in Paulownia tomentosa under Salt Stress. Frontiers in Plant Science. 7. 21 indexed citations
17.
Ouyang, Ruizhuo, Yang Yang, Tong Xiao, et al.. (2016). Potent anticancer activity of a new bismuth (III) complex against human lung cancer cells. Journal of Inorganic Biochemistry. 168. 18–26. 35 indexed citations
18.
Chen, Hongxia, Yupeng Lei, Jianyong Chen, et al.. (2015). Lymphangiogenesis in Gastric Cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis. BMC Cancer. 15(1). 103–103. 42 indexed citations
19.
Tang, Wei, Lun Chen, Lingxiao Pan, et al.. (2015). Prophylactic Effect of Lamivudine for Chemotherapy-Induced Hepatitis B Reactivation in Breast Cancer: A Meta-Analysis. PLoS ONE. 10(6). e0128673–e0128673. 6 indexed citations
20.
Pan, Lingxiao, Jin Gao, Lun Chen, et al.. (2014). Prognostic value of miR-106b expression in breast cancer patients. Journal of Surgical Research. 195(1). 158–165. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucas Fass Breakdown of academic impact, for papers by Fuchun Guo Breakdown of academic impact, for papers by Minhong Tang Breakdown of academic impact, for papers by Xiaoyi Zhang Breakdown of academic impact, for papers by Bingchen Han Breakdown of academic impact, for papers by Santanu Maji Breakdown of academic impact, for papers by Sahar Safaei Breakdown of academic impact, for papers by Rongkai Xie Breakdown of academic impact, for papers by Zike Yang
Rankless by CCL
2026